Danaparoid (Orgaran)
Revision as of 19:45, 27 February 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Venous thromboembolism (VTE) medications" to "Category:Venous thromboembolism medications")
General information
Class/mechanism: Low molecular weight heparin
History of changes in FDA indication
- 6/26/2001: Initial FDA approval
Also known as
- Brand name: Orgaran